Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4639922
Max Phase: Preclinical
Molecular Formula: C24H30N6O8S
Molecular Weight: 562.61
Molecule Type: Unknown
Associated Items:
ID: ALA4639922
Max Phase: Preclinical
Molecular Formula: C24H30N6O8S
Molecular Weight: 562.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N[C@@H](Cc1ccc(O)cc1)C(=O)NS(=O)(=O)OC[C@H]1OC[C@@H](CCn2nnc(-c3ccccc3)n2)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C24H30N6O8S/c25-19(12-15-6-8-18(31)9-7-15)24(34)28-39(35,36)38-14-20-22(33)21(32)17(13-37-20)10-11-30-27-23(26-29-30)16-4-2-1-3-5-16/h1-9,17,19-22,31-33H,10-14,25H2,(H,28,34)/t17-,19+,20-,21+,22-/m1/s1
Standard InChI Key: WIXKRGRTDDGDQH-KMKNWIINSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 562.61 | Molecular Weight (Monoisotopic): 562.1846 | AlogP: -0.88 | #Rotatable Bonds: 11 |
Polar Surface Area: 212.01 | Molecular Species: ACID | HBA: 13 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.74 | CX Basic pKa: 6.40 | CX LogP: -0.39 | CX LogD: -0.29 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.19 | Np Likeness Score: -0.22 |
1. De Ruysscher D, Pang L, Mattelaer CA, Nautiyal M, De Graef S, Rozenski J, Strelkov SV, Lescrinier E, Weeks SD, Van Aerschot A.. (2020) Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase., 28 (15): [PMID:32631562] [10.1016/j.bmc.2020.115580] |
Source(1):